scholarly journals HIGH VERSUS STANDARD PROTEIN DIETS IN OBESE PATIENTS WITH HEART FAILURE: EFFECTS ON CHRONIC DISEASE RISKS

2017 ◽  
Vol 69 (11) ◽  
pp. 850
Author(s):  
Lorraine S. Evangelista ◽  
Dawn Lombardo ◽  
Tamara Horwich ◽  
Michele Hamilton ◽  
Gregg Fonarow
Circulation ◽  
2017 ◽  
Vol 135 (suppl_1) ◽  
Author(s):  
Lorraine S Evangelista ◽  
Dawn Lombardo ◽  
Tamara Horwich ◽  
Michele Hamilton ◽  
Gregg C Fonarow

Background: There is controversy over dietary protein’s effect on long-term chronic disease risks in overweight and obese patients with heart failure. The aim of this study was to compare the effects of two calorie-restricted diets differing in protein content on chronic disease risks (e.g., weight, adiposity, glycemic control, lipid profiles, and blood pressure). Methods: A total of 97 overweight and obese (mean body mass index [BMI], 37.0 ± 6.2 kg/m 2 ) patients with heart failure, aged 58.8 ± 9.7 years, 70% males, consumed two diets, each for 12 weeks, in a randomized controlled design. The diets were: (1) a high protein diet (30% protein, 40% carbohydrates, and 30% fat) and (2) a standard protein diet (15% protein, 55% carbohydrates, and 30% fat). Their effects on weight (BMI) visceral fat (i.e. waist circumference), glycemic control (i.e. glycosylated hemoglobin [HgbA1C]), lipid profiles (total cholesterol [TC], low-density lipoprotein [LDL], high-density lipoprotein [HDL], triglycerides [TG]), and blood pressure at the beginning and end of each dietary intervention were analyzed. Results: Both diets were equally effective in promoting weight loss and visceral fat loss and in improving TC, but the high protein diet decreased to a greater extent HgbA1C levels ( P < 0.001) when compared with the standard protein diet. The high protein diet improved significantly TG levels ( P < 0.001) and both systolic and diastolic blood pressures when compared with the standard protein diet ( P < 0.001 and P < 0.001, respectively, see figure). No differences were noted in LDL and HDL levels. Conclusion: Energy restricted diets facilitate weight loss and visceral fat loss and lower TC in overweight and obese patients with heart failure. However, the high protein diet promoted better improvements in TG levels, glycemic control, and blood pressure than the standard protein diet, and may be superior in reducing chronic disease risks and potentially slowing the progression of disease in this population.


2010 ◽  
Vol 19 (13-14) ◽  
pp. 1855-1860 ◽  
Author(s):  
Åsa Franzén-Dahlin ◽  
Monica Rydell Karlsson ◽  
Märit Mejhert ◽  
Ann-Charlotte Laska

JAMA ◽  
2016 ◽  
Vol 315 (23) ◽  
pp. 2619 ◽  
Author(s):  
Dalane W. Kitzman ◽  
Mark J. Haykowsky ◽  
William Kraus

2020 ◽  
Vol 27 (2) ◽  
pp. 230-239 ◽  
Author(s):  
Saveria Femminò ◽  
Pasquale Pagliaro ◽  
Claudia Penna

The incidence of obesity and diabetes is increasing rapidly worldwide. Obesity and metabolic syndrome are strictly linked and represent the basis of different cardiovascular risk factors, including hypertension and inflammatory processes predisposing to ischemic heart disease, which represent the most common causes of heart failure. Recent advances in the understanding of ischemia/reperfusion mechanisms of injury and mechanisms of cardioprotection are briefly considered. Resistance to cardioprotection may be correlated with the severity of obesity. The observation that heart failure obese patients have a better clinical condition than lean heart failure patients is known as “obesity paradox”. It seems that obese patients with heart failure are younger, making age the most important confounder in some studies. Critical issues are represented by the &quot;obesity paradox” and heart failure exacerbation by inflammation. For heart failure exacerbation by inflammation, an important role is played by NLRP3 inflammasome, which is emerging as a possible target for heart failure condition. These critical issues in the field of obesity and cardiovascular diseases need more studies to ascertain which metabolic alterations are crucial for alleged beneficial and deleterious effects of obesity.


JAMA ◽  
2016 ◽  
Vol 315 (23) ◽  
pp. 2618
Author(s):  
Dimitrios Farmakis ◽  
John Parissis ◽  
Gerasimos Filippatos

Sign in / Sign up

Export Citation Format

Share Document